UCB SA (UCB)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

€232.30

Buy

€239.40

arrow-down€-2.40 (-1.01%)

Prices updated at 17 Dec 2025, 16:37 CET

Prices minimum 15 mins delay

Prices in EUR

UCB SA is engaged in the development of novel therapies for the treatment of central nervous system and immunological diseases.

FTSE EuroFirst 300

-0.03%

Brussels

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Charles-Antoine Janssen

CEO

Mr. Jean-Christophe Tellier

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

9,378

Head office

Allee de la Recherche, 60

Brussels

Belgium

B-1070

+32 25599999

Antje.Witte@ucb.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Ulf Wiinberg Independent Director	-
Mr. Jonathan M. Peacock Chairman of the Board	-
Mr. Jean-Christophe Tellier Director and Chief Executive Officer	-
Dr. Jan Berger Independent Director	-
Dr. Dolca Thomas, M.D. Independent Director	-
Ms. Maelys Castella Independent Director	-
Ms. Kay Davies Independent Director	-
Ms. Susan Gasser Independent Director	-
Mr. Pierre Gurdjian Independent Director	-
Mr. Charles-Antoine Janssen Vice Chairman of the Board	-
Mr. Cedric van Rijckevorsel Director	-
Mr. Cyril Janssen Director	-
Mr. Rodolfo J. Savitzky Independent Director	-
Ms. Nefertiti Greene Independent Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Fidelity Management & Research Company LLC	10,283,111
Vanguard Group Inc	3,643,059
Wellington Management Company LLP	3,485,243
Vanguard Health Care Fund	3,328,553
BlackRock Investment Management (UK) Ltd.	2,530,789

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.